Document is current

Article History

Received: 12 May 2020

Revised: 10 September 2020

Accepted: 29 September 2020

First Online: 10 November 2020

Conflict of interest

: In the last 5 years, <b>Z.J.D.</b> has received research and equipment in-kind support for an investigator-initiated study through Brainsway Inc and Magventure Inc. His work was supported by the Ontario Mental Health Foundation (OMHF), the Canadian Institutes of Health Research (CIHR), the National Institutes of Mental Health (NIMH) and the Temerty Family and Grant Family and through the Centre for Addiction and Mental Health (CAMH) Foundation and the Campbell Institute. <b>D.M.B.</b> has received research support from CIHR, NIH, Brain Canada and the Temerty Family through the CAMH Foundation and the Campbell Research Institute. He receives research support and in-kind equipment support for an investigator-initiated study from Brainsway Ltd. and he is the site principal investigator for three sponsor-initiated studies for Brainsway Ltd. He also receives in-kind equipment support from Magventure for an investigator-initiated study. He receives medication supplies for an investigator-initiated trial from Indivior. <b>P.B.F.</b> is supported by a Practitioner Fellowship grant from National Health and Medical Research Council (NHMRC) (1078567). In the last 3 years PBF has received equipment for research from Magventure A/S, Medtronic Ltd, Neurosoft and Brainsway Ltd. He has served on a scientific advisory board for Bionomics Ltd and LivaNova and is a founder and director of TMS Australia. <b>A.T.H.</b> is currently supported by an Alfred Deakin Postdoctoral Research Fellowship. <b>I.H.</b> has nothing to disclose. <b>R.Z.</b> has nothing to disclose. <b>Y.S.</b> has nothing to disclose.